Company
Headquarters: Tokyo, Japan
Employees: 342
¥7.02 Billion
JPY as of July 1, 2025
US$49.0 Million
| Company | Market Cap (USD) |
|---|---|
| Veeva Systems Inc. | $46.46 B |
| GE HealthCare | $34.85 B |
| Change Healthcare Inc. | $9.03 B |
| M3, Inc. | $8.98 B |
| Pro Medicus Limited | $8.96 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
WDB coco Co., Ltd. operates as a contracted drug development company. It supports the development of pharmaceuticals and medical devices with a focus on safety information management. The company was founded in 1984 and is headquartered in Tokyo, Japan.
WDB coco Co. Ltd has the following listings and related stock indices.
Stock: JPX: 7079 wb_incandescent